Tailoring iPSC Therapies for Autoimmune Diseases to Address Unmet Patient Needs

Time: 9:30 am
day: Conference Day Two


  • Delving into the potential of using patient-derived iPSCs to create targeted cell therapies for specific autoimmune diseases
  • Regulating the immune system and achieving disease remission in autoimmune conditions
  • Developing rigorous preclinical models that accurately reflect the human immune response to assess the safety and effectiveness of iPSC therapies for autoimmune diseases